30 Nov 2023 Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States Member news
29 Nov 2023 Sequana Medical announces positive data from non-randomized cohort in US Phase 1/2a MOJAVE study of DSR® 2.0 for treatment of heart failure Member news
29 Nov 2023 Agomab appoints Angelika Jahreis as Member of the Board of Directors and Andrea Sáez as Chief Development Officer Member news
28 Nov 2023 argenx reports topline results from ADVANCE-SC study of VYVGART Hytrulo in primary immune thrombocytopenia Member news
22 Nov 2023 Biocartis Holdings Inc.: Recapitalization completed and product portfolio expansion Member news
16 Nov 2023 argenx announces European Commission approval of subcutaneous VYVGART® (efgartigimod alfa) for generalized myasthenia gravis Member news
15 Nov 2023 Orionis Biosciences announces first patient dosed in Phase 1 clinical trial of ORB-011 in patients with advanced solid tumors Member news
14 Nov 2023 SwiftPharma and PlantForm target blockbuster cancer drug with new contract manufacturing agreement for plant-made biosimilars Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
